OXLUMO (lumasiran) for the Treatment of Primary Hyperoxaluria Type 1 (PH1)

Image 1-OXLUMO (lumasiran)
OXLUMO™ (lumasiran) is the first and only FDA-approved therapy for primary type 1 hyperoxaluria. Credit: Business Wire.